Pneumotox

Pneumotox® : The drug-Induced/iatrogenic respiratory disease website & App

The companion website and App Cardiotox® cover drug-Induced and iatrogenic cardiotoxicity



By Philippe Camus MD Professor (emeritus) (board-certified pulmonary medicine, cardiology) - Université Bourgone-Europe, Dijon, France.



Pneumotox is an aid to the diagnosis and management of respiratory diseases and reactions suspected of being induced by drugs, chemicals, or of iatrogenic origin..



Causality assessment and exact diagnosis are the full responsibility of the user.



Pneumotox is designed to provide regularly-updated information on drugs causing pulmonary toxicity (n >1,700 as of August 2026), patterns of involvement (> 820) and bibliography within minutes. That may be the crux in emergency situations. Yet, double-checking in and from other sources is indicated.



Pneumotox rests on a bibliographic repository built since 1978, which amounts to >50,000 references, the vast majority of which being indexed in PubMed. All references were and are being carefully reviewed for reliability and causality by the founder, then indexed under the umbrella of the corresponding drug or agent.



One can access Pneumotox by causative drugs, chemicals, herbals, substances of abuse, inhaled incl. e-cigarettes, vaping, or inhalants, gases, or by patterns of involvement for the corresponding list of causal drugs or agents.



Drug names are generic (International Nonproprietary Names (INN), alphabetical), not brand names. It may be appropriate to check the exact composition of any proprietary drug, as any other added substance or excipient can be toxic. Patterns are grouped by families according to the main anatomic site of involvement.



If a drug or drug reaction is listed in Pneumotox, this does not equate the patient is demonstrating toxicity. A “Diagnosing DIRD” window in Pneumotox may help securte the diagnosis. Lack of case or cases in the literature or in Pneumotox does not exclude a diagnosis of drug toxicity as there may be unpublished cases, you may be seeing the first case ever, or we may have overlooked some information. In such situations, Pneumotox cannot be held responsible. At any rate, the founder of Pneumotox can be contacted by mail 7/7.



In any patient, particularly the one with acute respiratory failure, ARDS or bronchospasm, exposure to drugs, substances, and/or chemicals must be done exhaustively with the patient, family, health professionals, pharmacy and/or law enforcement personel. This can be life-saving.

Early sampling of body fluids for drug and/or metabolites is indicated as early as possible, particularly in the severely ill. Knowledge of toxidromes and antidotes is also precious.



Where in doubt, consider double-checking PubMed, your affiliated Safety for Medicines Department/Agency and the Pharmacovigilance Department of drug companies. They may host more and/or undisclosed information.



Patients should be reassured as such incidents are rare. If needed, they are invited to consult with their treating physicians.



You may contact Pneumotox almost 24/7 through the contact window.



The companion website and App Cardiotox® covers drug-Induced and iatrogenic cardiotoxicity



ALL RIGHTS RESERVED

The current version of Pneumotox website and App were developed by Akyos Communication, Dijon, France



Pneumotox received a generous Grant from the ERS in 2019